The Max Foundation

Home

MaxAid

Who we are

What we do

The Max Foundation’s Medical Board Members

Andreas Hochhaus, MD

Klinikum Mannheim der University Heidelberg in Mannheim, GERMANY.

Brian J. Druker, MD

Investigator, Howard Hughes Medical Institute, JELD-WEN Chair of Leukemia Research, USA.

Francois Guilhot, MD

Head of the Department of Oncology, Hematology and Cell Therapy at The University Hospital of Poitier. President of the Chronic Myelogenous Leukemia French Group, FRANCE.

George D. Demetri, MD

Director of the Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute Associate Professor of Medicine, Harvard Medical School, USA.

John M. Goldman, MD

Chairman, Department of Hematology, Imperial College Faculty of Medicine General Secretary of the World Marrow Donor Association, UK.

Jorge E. Cortes, MD

Professor of Medicine, Chief/CML Section, Deputy Chair, Department of Leukemia, MD Anderson Cancer Center in Houston, Texas, USA.

Josy Reiffers, MD

Service des Maladies du Sang, C.H.U. de Bordeaux of Centre François Magendie, FRANCE.

Michele Baccarani, MD

Head of the Institute of Hematology and Medical Oncology "L. and A. Seràgnoli", S. Orsola at the University Hospital, Bologna, ITALY.

Moshe Talpaz, MD

Assoc. Director for Translational Research, The University of Michigan Health Systems, Ann Arbor, Michigan, USA.

Oliver Gerhard Ottmann, MD

Head of the Laboratory of Cell Biology and Experimental Hematology, Medizinische Klinik III, at the J.W. Goethe University in Frankfurt, GERMANY.

Stephen Gerard O'Brien, MD

Senior Lecturer in the department of Hematology, University of Newcastle and Honorary Consultant Hematologist, Royal Victoria Infirmary, UK.

Tim Hughes, Prof

Hanson Institute, SA Pathology Adelaide, SOUTH AUSTRALIA.

Thomas Fischer III, MD

Head of the Department of Hematology/Oncology at the University of Magdeburg, GERMANY.